Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,057,000 | 2,574,000 | 2,789,059 | 2,889,749 | 2,625,592 |
| Depreciation Amortization | 345,000 | 278,000 | 302,232 | 265,477 | 212,944 |
| Income taxes - deferred | -98,000 | -39,000 | 64,061 | 12,152 | -42,013 |
| Accounts receivable | -315,000 | 198,000 | -375,736 | -348,875 | -356,462 |
| Accounts payable and accrued liabilities | -98,000 | 117,000 | 428,944 | -4,453 | 203,641 |
| Other Working Capital | -562,000 | 108,000 | 211,853 | -680,380 | 30,209 |
| Other Operating Activity | 776,000 | -41,000 | 218,597 | 700,243 | 406,143 |
| Operating Cash Flow | $3,105,000 | $3,195,000 | $3,639,010 | $2,833,913 | $3,080,054 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 315,000 | -672,000 | 4,310,357 | -1,784,867 | -738,027 |
| PPE Investments | -190,000 | -397,000 | -131,904 | -61,884 | -230,057 |
| Net Acquisitions | -379,000 | -10,752,000 | -588,608 | -91,000 | -1,247,816 |
| Purchase Of Investment | N/A | -25,000 | 0 | N/A | N/A |
| Investing Cash Flow | $-254,000 | $-11,846,000 | $3,589,845 | $-1,937,751 | $-2,215,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,774,000 | 2,358,000 | 4,696,850 | 2,962,500 | 400,000 |
| Debt Repayment | -4,440,000 | -1,839,000 | -687,697 | -868,408 | -711,103 |
| Common Stock Issued | 313,000 | 466,000 | 211,737 | 376,648 | 222,728 |
| Common Stock Repurchased | -582,000 | -667,000 | -2,383,132 | -4,022,593 | -998,495 |
| Other Financing Activity | -609,000 | 245,000 | -74,189 | 213,143 | 35,432 |
| Financing Cash Flow | $-2,544,000 | $563,000 | $1,763,569 | $-1,338,710 | $-1,051,438 |
| Exchange Rate Effect | 2,000 | 8,000 | -16,526 | 77,469 | 940 |
| Beginning Cash Position | 1,804,000 | 9,884,000 | 907,879 | 1,272,958 | 1,459,302 |
| End Cash Position | 2,113,000 | 1,804,000 | 9,883,777 | 907,879 | 1,272,958 |
| Net Cash Flow | $309,000 | $-8,080,000 | $8,975,898 | $-365,079 | $-186,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,105,000 | 3,195,000 | 3,639,010 | 2,833,913 | 3,080,054 |
| Capital Expenditure | -190,000 | -397,000 | -131,904 | -61,884 | -230,057 |
| Free Cash Flow | 2,915,000 | 2,798,000 | 3,507,106 | 2,772,029 | 2,849,997 |